Jubilant Pharmova Limited (BOM:530019)
1,097.55
-22.05 (-1.97%)
At close: Oct 31, 2025
Jubilant Pharmova Employees
Jubilant Pharmova had 5,547 employees as of March 31, 2025. The number of employees increased by 148 or 2.74% compared to the previous year.
Employees
5,547
Change (1Y)
148
Growth (1Y)
2.74%
Revenue / Employee
13.73M INR
Profits / Employee
861.19K INR
Market Cap
185.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5,547 | 148 | 2.74% |
| Mar 31, 2024 | 5,399 | 1,039 | 23.83% |
| Mar 31, 2023 | 4,360 | -1,465 | -25.15% |
| Mar 31, 2022 | 5,825 | 25 | 0.43% |
| Mar 31, 2021 | 5,800 | -2,200 | -27.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Jubilant Pharmova News
- 24 days ago - Jubilant Pharmova subsidiary launches new high-speed isolator-based line at US facility, adds 50% capacity - Business Upturn
- 3 months ago - Jubilant Pharmova receives 4 observations from USFDA after Pre-Approval Inspection at Roorkee facility - Business Upturn
- 3 months ago - Jubilant Food Share Price Target 2022 - ABC Money
- 4 months ago - QSR sector faces rising competition; CLSA cautious on Jubilant and Westlife, positive on Devyani and RBA - Business Upturn
- 11 months ago - Jubilant to buy 40% in Coke bottler's parent for 10k cr - The Times of India
- 1 year ago - Bernstein maintains Outperform rating on Jubilant Foodworks, highlights three pillars to achieve $10 billion market cap - Business Upturn
- 1 year ago - Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - Benzinga
- 1 year ago - CLSA maintains ‘Underperform’ rating on Jubilant FoodWorks with target price of Rs 445, expecting 26% downside - Business Upturn